Vascular Solutions floats at second attempt:
This article was originally published in Clinica
Vascular Solutions has raised $42 million in its initial public offering, its second attempt at flotation. Vascular recently received US FDA approval for its arterial puncture closure device, Duett, and has been named in a patent lawsuit with St Jude Medical, which manufactures under licence the Angio-Seal haemostasis puncture closure device (see Clinica No 917, p 1). The Minneapolis, Minnesota-based company postponed an offering in October 1999, citing the turbulent condition of the stock market.